Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
July 20, 2020 at 07:23 am EDT
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 203.611 million compared to CNY 207.678 million a year ago. Operating income was CNY 33.752 million compared to CNY 6.276 million a year ago. Net income was CNY 26.966 million compared to CNY 8.595 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.03 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.